1.
May P, Rassner M, Hoegner M, Shahbaz W, Wäsch R, Martinez AM, Schmidt B, Theurich S, Engelhardt M, Bassermann F, Jung J. Ixazomib maintenance therapy in transplant-eligible multiple myeloma: real-world evidence from three large German centers. haematol [Internet]. 2020Sep.10 [cited 2025Dec.5];. Available from: https://haematologica.org/article/view/12945